CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
Resorbable Meshdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02053168
NCT02053168N/ACompleted

A Prospective, Multicenter All Comers Study of a Novel Resorbable Mesh (Phasix Mesh) for Ventral or Incisional Hernia Repair

C. R. Bard·interventional·Posted Feb 3, 2014·Updated May 11, 2018

In Brief

A clinical study evaluating Resorbable Mesh for Ventral Hernia and Incisional Hernia. Completed, enrolled 33 participants across 6 sites.

Detailed Summary

Collect data on safety, performance, and effectiveness of Phasix Mesh in subject requiring primary ventral and incisional hernias.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 3, 2014
Enrollment StartFeb 1, 2014
Primary CompletionFeb 23, 2017
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 12.4 years ago

Interventions

Resorbable Meshdevice

Phasix Mesh